Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Inhibrx Announces Enrollment of First Patient in INBRX-101 Study

americanpharmaceuticalreviewSeptember 06, 2019

Tag: disease , Respiratory , InhibRx , AATD , INBRX-101

PharmaSources Customer Service